Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure. - Wikidata - awgldk - TriplyDB

Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

http://www.wikidata.org/entity/Q46208536

about

A validated model of serum anti-müllerian hormone from conception to menopause Human ovarian reserve from conception to the menopause Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging Health and fertility in World Health Organization group 2 anovulatory women Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications ABO blood group and ovarian reserve: a meta-analysis and systematic review.The Protective Effect of N-Acetylcysteine on Ionizing Radiation Induced Ovarian Failure and Loss of Ovarian Reserve in Female Mouse.Anti-Müllerian hormone (AMH) as a good predictor of time of menopause Anti-Müllerian hormone and inhibin B variability during normal menstrual cycles.Can egg donor selection be improved?--A pilot study Oncofertility and preservation of reproductive capacity in children and young adults.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone.Reproductive capacity in iron overloaded women with thalassemia major.Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.Chemotherapy-Induced Amenorrhea - An Update Comparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve.Fertility potential in thalassemia major women: current findings and future diagnostic tools.Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.Possible role of autoimmunity in patients with premature ovarian insufficiency In vitro fertilization outcomes in women with surgery induced diminished ovarian reserve after endometrioma operation: Comparison with diminished ovarian reserve without ovarian surgery.Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.Anti-mullerian hormone: a new marker of ovarian function.Cytokines in ovarian folliculogenesis, oocyte maturation and luteinisation.Premature ovarian insufficiency: from pathogenesis to clinical management.Fertility after uterine artery embolization: a review.Chemotherapy-induced damage to ovary: mechanisms and clinical impact.Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.American ginseng regulates gene expression to protect against premature ovarian failure in rats.Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa.Pregnancy following ovarian induction in a patient with premature ovarian failure and undetectable serum anti-Müllerian hormone.Ovarian reserve in young women of reproductive age with Crohn's disease.Anti Müllerian hormone levels before and after uterine artery embolization: A preliminary report.Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.Continuous high-dose estrogen controls serum FSH and LH levels: new treatment strategy for extremely low ovarian reserve patients, two case reports.

P2860

Q21135308-90310C40-1FAF-4FFB-BE62-952BB173F6EE Q21142673-36AB77DB-69B5-436C-8815-F4BE94C95456 Q27026188-599708E5-E761-4159-B6A5-C3F364388251 Q27026624-652D961B-430F-4A60-B834-A31B660299A0 Q28239980-2A5B3DEF-9E71-4BA3-8196-B880FC27BE3F Q33648972-D351303F-6DD8-4D02-A7A8-F570BF2BE630 Q33760075-52DAE3F9-264C-4B2B-ADA4-73D084AD8D7B Q33903528-C4F68778-9976-49B3-98BC-6C20D1AA4532 Q33937262-F6D2E629-F58E-4689-8099-6680EF308861 Q33986762-917054F0-B85D-4648-A7B6-64403C44804D Q34180625-9C33FEF7-42A2-4C84-8812-4E7242AC90DF Q34255040-2D268F20-2C0B-4E15-A14F-0BD8A491F6C1 Q34371743-B83E3BA7-6DBA-4C83-9582-FB111D1EEB4B Q34392414-5CDC9D65-2949-48C6-8B1B-41E06A882543 Q34954420-F3A93C6C-EC6D-4ECE-9647-AE7DBC788EA8 Q35212404-32C09935-62D5-465E-B76C-14E975EB8AEB Q35767868-2BD7227C-98F7-47C1-8A91-8A1B7EC64FB8 Q35924430-4F2718C5-79D9-44A6-B732-A069B05A74C6 Q36295133-14B9EED3-371B-485D-82FE-6074CDF4339E Q36706499-2F6AA313-4D3C-4C75-9A9C-330C69F792E0 Q37357809-B7620584-9275-4270-9EDD-F60EE4181DDF Q37380100-1A7B2D9A-E1FB-4CA9-ADF3-E36A1D959CA6 Q37512512-154163CC-A401-447C-BE59-6AD2AA6B741F Q37647340-41EED174-2E8C-41FE-8A1B-42BEA6D30765 Q37671819-CEA87EDD-CC43-4D2B-92FB-01DFC6307311 Q37699609-6FA2E9D0-A5EC-4F86-8B7D-B036EC991C21 Q38165903-78F25B65-4BEC-4DAF-8F4C-541325B06158 Q38321876-357DC676-8A61-43FE-8562-47BEBC2D2677 Q38578592-B3CF2DB7-DD62-4EA9-8B6B-DC7CC7D4242A Q38842887-22D827B4-F4CF-4F06-9098-D25B5B092251 Q41293426-C4086028-3180-4570-ACA3-C2C1AE3E2593 Q41887134-8DBD27E2-3200-4E94-8B79-8EFC0932ECF8 Q44883818-03F4AD6A-7DE8-4AD9-8F3A-301E4608B73E Q46193678-956CCEB0-767D-4AD9-8BAC-9B48F41BE6F8 Q46759980-D40523F1-C23E-49F7-8CC7-108A5F4B243F Q46824843-9A0F8030-A97C-404D-A7B6-F1EDD64F6F1C Q47127165-7EDCE327-39FD-4560-BD03-B09AD5B648C7 Q47170320-797325C2-71F8-4766-B44F-F565DE5E50A1 Q47369122-7D7B7AA5-BF98-42E6-B58C-E72CD0FE822A Q48611108-F06F327B-67F0-4261-8562-475D3B2E8FDE

P2860

Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.

http://www.wikidata.org/entity/Q46208536

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@en

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@nl

type

label

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@en

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@nl

prefLabel

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@en

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@nl

P1433

Q46208536-5E898017-8E26-47A4-8758-65F4E6A801A6

P1476

Q46208536-9611F99D-FF76-43D8-BAD2-FF81B27F0106

P2093

Q46208536-01AC792F-2DEA-4B69-87F9-F9FA1ABB4E1D

Q46208536-1FDF68B8-644E-4813-B91E-F0A4743936B1

Q46208536-23FFBCD9-3384-4471-BB11-333F142C9620

Q46208536-26310DF9-3086-4548-BDB9-61EB36A1D365

Q46208536-2642F487-B36D-4D82-A603-0A41684EB713

Q46208536-531FD547-8495-475E-BB41-B63DCC097089

Q46208536-62DFAF33-50CF-4EED-88D1-86F525027E90

Q46208536-6757094D-94F9-4609-82A7-AAD67E2D0225

Q46208536-68E9D086-7C1D-4BFA-97C9-CA4998B97B0B

Q46208536-74AD5ED6-E7E0-406E-8B8E-55764085E00C

P304

Q46208536-D59763E3-8BF9-4ACC-BE73-952A59844C93

P31

Q46208536-25923B35-8B82-427C-8A08-3F92A71DFF62

P356

Q46208536-53293CDC-5F2B-4B6A-8B8E-E9E716CD6C97

P407

Q46208536-1EDE690F-5F51-4012-8ADF-4348FFAF211D

P433

Q46208536-D9170863-61DE-4775-8B56-10E8486B57E8

P478

Q46208536-BBB156FB-A47E-44EC-9231-93DEAE5957E1

P577

Q46208536-E7393EA9-B971-463A-8EFC-89E8DFF2FFBE

P5875

Q46208536-8A266C79-E928-4C02-8D03-1D6FA43C6821

P698

Q46208536-33DD78EF-83CB-42A6-8244-BD3C34A20C4A

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Anti-Mullerian hormone, inhibi ...... ng women with ovarian failure.

@en

P2093

Angelique J Goverde

http://www.w3.org/2001/XMLSchema#string

Annemieke Hoek

http://www.w3.org/2001/XMLSchema#string

Axel P N Themmen

http://www.w3.org/2001/XMLSchema#string

Bart C J M Fauser

http://www.w3.org/2001/XMLSchema#string

Catharina C M Beerendonk

http://www.w3.org/2001/XMLSchema#string

Cornelius B Lambalk

http://www.w3.org/2001/XMLSchema#string

Dutch Premature Ovarian Failure Consortium

http://www.w3.org/2001/XMLSchema#string

Erik A H Knauff

http://www.w3.org/2001/XMLSchema#string

Frank H de Jong

http://www.w3.org/2001/XMLSchema#string

Frank J M Broekmans

http://www.w3.org/2001/XMLSchema#string

P304

786-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-1818

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23641664

http://www.w3.org/2001/XMLSchema#string

P698

19066296

http://www.w3.org/2001/XMLSchema#string